Market assessment of a "bioactive sol-gel-derived borate glass platform technology"

麦吉尔大学开发了一种基于Sol-Gel的平台技术，该技术正在申请专利，可以生产具有不同化学和纹理特性的定制生物活性硼酸盐玻璃配方。到目前为止，这些独特的生物材料在骨和牙齿矿化以及在伤口愈合方面的应用方面表现出了巨大的潜力。溶胶-凝胶工艺在低温下产生这些生物材料，提供可调的表面和地形特征，从而增强细胞响应，并潜在地促进更快的组织再生。治疗性离子可以很容易地结合到玻璃结构中，然后可以在降解时可控地释放。因此，该平台技术在软硬组织再生方面具有广泛的应用潜力。为此，NSERC创新市场评估申请的目的是进行市场研究，以探索和验证生物活性硼酸盐玻璃技术平台最具吸引力的应用的需求和市场潜力，并确定这些极具前景的生物材料的最佳商业化战略。

McGill University has developed a patent-pending sol-gel based platform technology that generates bespoke, bioactive borate glass formulations with distinct chemical and textural properties. These unique biomaterials have so far demonstrated great potential in bone and teeth mineralization as well as in applications in wound healing. The sol-gel processing produces these biomaterials under low temperature, providing tunable surface and topographical features thus enhancing cellular responses and can potentially promote quicker tissue regeneration. Therapeutic ions can be easily incorporated into the glass structure, which can then be controllably released upon degradation. Therefore, this platform technology has significant potential in broad range applications for the regeneration of both hard and soft tissues. To this end, the purpose of this NSERC Idea to Innovation Market Assessment application is to undertake market research in order to explore and validate the needs and market potential of the most attractive applications for the bioactive borate glass technology platform, and to determine the optimum commercialization strategy for these highly promising biomaterials.